Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant

Vaccinating recovered patients previously infected by COVID-19 with mRNA vaccines to boost their immune response against wild-type viruses (WT), we aimed to investigate whether vaccine platform and time of vaccination affect immunogenicity against the SARS-CoV-2 WT and Delta variant (DV). Convalesce...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruiqi, Khong, Ka-Wa, Leung, Ka-Yi, Liu, Danlei, Fan, Yujing, Lu, Lu, Chan, Pui-Chun, Chen, Linlei, To, Kelvin Kai-Wang, Chen, Honglin, Yuen, Kwok-Yung, Chan, Kwok-Hung, Hung, Ivan Fan-Ngai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705363/
https://www.ncbi.nlm.nih.gov/pubmed/34960189
http://dx.doi.org/10.3390/vaccines9121442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705363/
https://www.ncbi.nlm.nih.gov/pubmed/34960189
http://dx.doi.org/10.3390/vaccines9121442

Ejemplares similares